| Entry |
|
|---|
| Name |
Pardoprunox (USAN/INN) |
|---|
| Formula |
C12H15N3O2
|
|---|
| Exact mass |
233.1164
|
|---|
| Mol weight |
233.27
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian, Dopamine receptor agonist |
|---|
| Comment |
Treatment of Parkinson's disease, restless legs syndrome
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
DG01324 Pardoprunox
D09397 Pardoprunox
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D09397 Pardoprunox (USAN/INN)
DRD3
D09397 Pardoprunox (USAN/INN)
Serotonin
HTR1A
D09397 Pardoprunox (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
DG01324 Pardoprunox
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C1x C 20.5800 -22.8200
2 N1y N 20.5800 -21.4200
3 C1x C 21.8400 -20.7200
4 C1x C 23.0300 -21.4200
5 N1y N 23.0300 -22.8200
6 C1x C 21.8400 -23.5200
7 C8y C 24.2900 -23.5200
8 C8y C 25.4800 -22.8200
9 C8y C 26.6700 -23.5200
10 C8x C 26.6700 -24.9200
11 C8x C 25.4800 -25.6200
12 C8x C 24.2900 -24.9200
13 O7x O 25.7600 -21.4200
14 C8y C 27.1600 -21.2800
15 N4x N 27.7200 -22.5400
16 O6a O 27.8600 -20.0900
17 C1a C 19.3900 -20.7200
BOND 19
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 7 12 2
14 8 13 1
15 13 14 1
16 14 15 1
17 9 15 1
18 14 16 2
19 2 17 1
|
|---|
